Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

PURPOSE: Patients with acute myeloid leukemia (AML) in remission remain at risk for relapse even after allogeneic hematopoietic cell transplantation (alloHCT). AML measurable residual disease (MRD) status before alloHCT has been shown to be prognostic. Whether modulation of the intensity of the allo...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Clin Oncol
Hoofdauteurs: Hourigan, Christopher S., Dillon, Laura W., Gui, Gege, Logan, Brent R., Fei, Mingwei, Ghannam, Jack, Li, Yuesheng, Licon, Abel, Alyea, Edwin P., Bashey, Asad, Deeg, H. Joachim, Devine, Steven M., Fernandez, Hugo F., Giralt, Sergio, Hamadani, Mehdi, Howard, Alan, Maziarz, Richard T., Porter, David L., Scott, Bart L., Warlick, Erica D., Pasquini, Marcelo C., Horwitz, Mitchell E.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2020
Onderwerpen:
RAPID COMMUNICATIONS
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7164487/
https://ncbi.nlm.nih.gov/pubmed/31860405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.03011
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items